title: Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.
abstract: Three bioactive sphingolipids, namely sphingosine-1-phosphate (S1P), ceramide (CER) and sphingosine (SPH) were shown to be involved in ischemia/reperfusion injury of the heart. S1P is a powerful cardioprotectant, CER activates apoptosis and SPH in a low dose is cardioprotective whereas in a high dose is cardiotoxic. The aim of the present study was to examine effects of experimental myocardial infarction on the level of selected sphingolipids in plasma, erythrocytes and platelets in the rat. Myocardial infarction was produced in male Wistar rats by ligation of the left coronary artery. Blood was taken from the abdominal aorta at 1, 6 and 24 h after the ligation. Plasma, erythrocytes and platelets were isolated and S1P, dihydrosphingosine-1-phosphate (DHS1P), SPH, dihydrosphingosine (DHS) and CER were quantified by means of an Agilent 6460 triple quadrupole mass spectrometer using positive ion electrospray ionization source with multiple reaction monitoring. The infarction reduced the plasma level of S1P, DHS1P, SPH and DHS but increased the level of total CER. In erythrocytes, there was a sharp elevation in the level of SPH and DHS early after the infarction and a reduction after 24 h whereas the level of S1P, DHS1P and total CER gradually increased. In platelets, the level of each of the examined compounds profoundly decreased 1 and 6 h after the infarction and partially normalized in 24 h. The results obtained clearly show that experimental heart infarction in rats produces deep changes in metabolism of sphingolipids in the plasma, platelets and erythrocytes.
authors.affiliation: Department of Cardiology, Medical University of Białystok, Poland. malgo33@interia.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Knapp
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Zendzian-Piotrowska
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Błachnio-Zabielska
authors.forename: Piotr
authors.initials: P
authors.lastname: Zabielski
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Kurek
authors.forename: Jan
authors.initials: J
authors.lastname: Górski
mesh_terms: D000758:Anesthesia; D000818:Animals; D002518:Ceramides / Q000097:blood*; D003331:Coronary Vessels / Q000601:surgery; D004906:Erythrocyte Count; D005263:Femoral Artery / Q000601:surgery; D008026:Ligation; D008246:Lysophospholipids / Q000097:blood; D008297:Male; D009203:Myocardial Infarction / Q000097:blood*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000378:metabolism; D010976:Platelet Count; D051381:Rats; D017208:Rats, Wistar; D013107:Sphingolipids / Q000097:blood; D013110:Sphingosine / Q000031:analogs & derivatives / Q000097:blood*; D020107:Troponin T / Q000097:blood; D000099157:Sphingosine Kinase
chemical_list: D002518:Ceramides; D008246:Lysophospholipids; D017853:Phosphotransferases (Alcohol Group Acceptor); D013107:Sphingolipids; D013110:Sphingosine; D020107:Troponin T; D000099157:Sphingosine Kinase; C060504:dihydrosphingosine 1-phosphate; C060506:sphingosine 1-phosphate; C005682:safingol